Fairfield Market Research Inhaled Nitric Oxide Market Share, Outlook, Size, 2022 - 2029

Inhaled Nitric Oxide Market

Global Industry Analysis (2018 - 2021) - Growth Trends and Market Forecast (2022 - 2029)

Published Date: Upcoming | Format:

Industry: Pharmaceuticals & Biotechnology

Request TOC Request Customization $4,995.00Prebook

Prevalence of Chronic Illnesses to Raise Demand of Inhaled Nitric Oxide

Prevalence of several chronic illnesses has raised concerns among individuals and healthcare facilities alike, as mortality rates caused by such diseases continue to increase. This has resulted in adopting new therapies such as use of inhaled nitric oxide to treat illnesses such as COPD, Asthma and PPHN. Moreover, increasing deaths due to such diseases has propelled demand for inhaled nitric oxide as it regulates and improves vascular muscle tone. According to WHO, deaths due to asthma in 2019 were around 461,000 across the globe and is the most prevailing chronic illness, especially among children. On the other hand, COPD (Chronic Obstructive Pulmonary Disease) is considered as a third major cause of death, which, in 2019, resulted in 3.23 million fatalities worldwide. Moreover, according to North American Pediatric Pulmonary Hypertension Network Registry, cases related to PPHN (Persistent Pulmonary Hypertension in Newborn) are expected to increase and result in high mortality rate. Inhaled nitric oxide enhances oxygenation, thus reducing shunting while enhancing ventilation perfusion matching, which can be used in treating chronic illnesses such as PPHN, COPD and asthma. This aspect is expected to drive the growth of the inhaled nitric oxide market in the coming years.

Use of Inhaled Nitric Oxide in Fighting COVID 19 to Influence Growth

Research on use of inhaled nitric oxide in treating COVID 19 is currently being conducted. Being an endogenous vasodilator, use of inhaled nitric oxide to target pulmonary vasculature particularly in conditions where higher pulmonary vascular resistance is needed is being researched upon. By far, research shows that inhaled nitric oxide improves oxygenation, which is a key aspect in fighting COVID 19. Moreover, pre-intubation application of inhaled nitric oxide in patients suffering from respiratory failure due to COVID 19 is likely to have a significant impact in enhancing patient outcomes. Different physiological effects provided by inhaled nitric oxide, such as inflammatory response, anti-microbial effect, airway permeability, neurotransmission and ciliary motility can play a crucial role in treating wide range of indications and symptoms of COVID 19. Potential of inhaled nitric oxide as a therapeutic agent in fighting COVID 19 is likely to pave potential opportunities in the coming years, consequently fuelling growth of inhaled nitric oxide market.

Side Effects Associated with iNO to Impede Growth of Inhaled Nitric Oxide Market

Although inhaled nitric oxide (iNO) has its potential benefits in fighting chronic ailments, there are few side effects caused due to over use of the chemical. Its use in oxygenation is related to cellular cGMP (cyclic GMP), whose increased rate can interfere with and have an adverse effect on normal cellular proliferation. In addition inhaled nitric oxide can also lead to breaking or causing alterations in DNA strands that are mutagenic. Inhaled nitric oxide can sometimes react with oxygen to produce nitrogen dioxide that is a potentially harmful irritant. Overdose or incorrect administration of inhaled nitric oxide can also lead to blocking of platelet aggregation, in turn causing methemoglobinemia. However, the complete toxic nature of inhaled nitric oxide is still in its research phase, the conclusion of which is expected to raise questions on its administration. This factor is expected to hinder growth of the inhaled nitric oxide market.

Inhaled Nitric Oxide Market to Witness Potential Growth Avenues in North America

Growing incidences of ARDS (Acute Respiratory Distress Syndrome) in developed countries of North America have played a major role in driving growth of inhaled nitric oxide market. For instance, according to NCBI (National Center for Biotechnology Information), cases of ARDS in United States are between 64.2- 78.9 per 100,000 person years. In addition, according to analysis of AAFA (Asthma and Allergy Foundation of America), around 25 million people in the region suffer from asthma and the disease is more common among adult women than men. This has resulted in adopting therapies that facilitate oxygenation of lungs in turn improving vascular health, which is expected to drive growth of the inhaled nitric oxide market in North America.

Inhaled Nitric Oxide Market Competitive Landscape

Some of the key players operating in the inhaled nitric oxide market include Nu-Med Plus, Air Liquide, Merck, Praxair Technology Inc., Mallinckrodt, VERO Biotech, Halma Plc, Bellerophon Therapeutics Inc., and Linde Plc.

Key Elements Included In The Study: Global Inhaled Nitric Oxide Market

  • Inhaled Nitric Oxide Market by Product/Technology/Grade, Application/End-user, and Region
  • Executive Summary (Opportunity Analysis and Key Trends)
  • Historical Market Size and Estimates, Value, 2018 - 2021
  • Market Value at Regional and Country Level, 2022 - 2029
  • Market Dynamics and Economic Overview
  • Market Size in Value, Growth Rates, and Forecast Figures, 2022 - 2029
  • Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
  • Regional and Product/Grade/Application/End-user Price Trends Analysis
  • Value Chain and Five Force’s Analysis
  • Regional/Sub-region/Country Market Size and Trend Analysis
  • Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

  • The report will be prepared in a PPT format and will be delivered in a PDF format.
  • Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.
  • If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.
  • If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.
  • If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.


  • The segmentation/company profiles/countries depicted above may vary in the actual report.

Request Table of Contents

Our Research Methodology

Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.

View Methodology
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services